Terms: = Kidney tumors AND CARS, P49589, 833, ENSG00000110619
76 results:
1. The Value of Dual-Energy Computed Tomography-Based Radiomics in the Evaluation of Interstitial Fibers of Clear Cell Renal Carcinoma.
Bing X; Wang N; Li Y; Sun H; Yao J; Li R; Li Z; Ouyang A
Technol Cancer Res Treat; 2024; 23():15330338241235554. PubMed ID: 38404055
[TBL] [Abstract] [Full Text] [Related]
2. Short-term outcomes of colorectal cancer surgery in patients with dialysis: a systematic review and meta-analysis.
Takano Y; Kai W; Kobayashi Y; Kanno H; Hanyu N
Langenbecks Arch Surg; 2023 Jul; 408(1):283. PubMed ID: 37464017
[TBL] [Abstract] [Full Text] [Related]
3. Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy.
Khaleel S; Truong H; Jiang S; K-Lee P; Davelman B; Gordon D; Benfante N; Arora A; Ostrovnaya I; Tickoo S; Coleman J; Hakimi AA; Russo P
Urol Oncol; 2023 Sep; 41(9):391.e5-391.e11. PubMed ID: 37423816
[TBL] [Abstract] [Full Text] [Related]
4. HGF-Based CAR-T Cells Target Hepatocellular Carcinoma Cells That Express High Levels of c-Met.
Ma H; Wei W; Liang D; Xu X; Yang D; Wang Q; Wang Y; Wei Q; Sun B; Zhao X
Immunol Invest; 2023 Nov; 52(6):735-748. PubMed ID: 37409941
[TBL] [Abstract] [Full Text] [Related]
5. Significant Incidental Findings in the National Lung Screening Trial.
Gareen IF; Gutman R; Sicks J; Tailor TD; Hoffman RM; Trivedi AN; Flores E; Underwood E; Cochancela J; Chiles C
JAMA Intern Med; 2023 Jul; 183(7):677-684. PubMed ID: 37155190
[TBL] [Abstract] [Full Text] [Related]
6. Screening of autoantibodies as biomarkers in the serum of renal cancer patients based on human proteome microarray.
Sun Y; Liu C; Zhong H; Wang C; Xu H; Chen W
Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 54(12):1909-1916. PubMed ID: 36789694
[TBL] [Abstract] [Full Text] [Related]
7. Alcoholic liver disease in relation to cancer incidence and mortality: Findings from a large, matched cohort study in South Korea.
Tran TPT; Han M; Luu NM; Oh JK
Cancer Med; 2023 Apr; 12(7):8754-8766. PubMed ID: 36653955
[TBL] [Abstract] [Full Text] [Related]
8. Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with Nivolumab.
Fujiwara R; Yuasa T; Yamamoto S; Fujiwara M; Takemura K; Urasaki T; Oki R; Komai Y; Oguchi T; Numao N; Yonese J
Nutr Cancer; 2023; 75(2):670-677. PubMed ID: 36448767
[TBL] [Abstract] [Full Text] [Related]
9. Nanobody-based CAR T cells targeting intracellular tumor antigens.
Li H; Zhong D; Luo H; Shi W; Xie S; Qiang H; Zhu L; Gao L; Liu J; Sun S; Ding Z; Yang X; Lu X
Biomed Pharmacother; 2022 Dec; 156():113919. PubMed ID: 36411612
[TBL] [Abstract] [Full Text] [Related]
10. Current and future perspectives on CAR-T cell therapy for renal cell carcinoma: A comprehensive review.
Kim TJ; Lee YH; Koo KC
Investig Clin Urol; 2022 Sep; 63(5):486-498. PubMed ID: 36067994
[TBL] [Abstract] [Full Text] [Related]
11. [Correlation between metabolic syndrome and prognosis of patients with clear cell renal cell carcinoma].
Zuo MN; DU YQ; Yu LP; Dai X; Xu T
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):636-643. PubMed ID: 35950385
[TBL] [Abstract] [Full Text] [Related]
12. Stereotactic Body Radiation Therapy for Metastases in Long Bones.
Madani I; Sahgal A; Erler D; Stish BJ; Olivier KR; Park SS; Eppinga WSC; Seravalli E; Redmond KJ; Cao Y; Siva S; Chang D; Nguyen TK; O'Neil M; Guckenberger M
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):738-746. PubMed ID: 35850362
[TBL] [Abstract] [Full Text] [Related]
13. Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US.
Ermer T; Canavan ME; Maduka RC; Li AX; Salazar MC; Kaminski MF; Pichert MD; Zhan PL; Mase V; Kluger H; Boffa DJ
JAMA Netw Open; 2022 Jun; 5(6):e2219535. PubMed ID: 35771575
[TBL] [Abstract] [Full Text] [Related]
14. The effect of toxic air pollutants on fertility men and women, fetus and birth rate.
Margiana R; Yousefi H; Afra A; Agustinus A; Abdelbasset WK; Kuznetsova M; Mansourimoghadam S; Ajam Ekrami H; Mohammadi MJ
Rev Environ Health; 2023 Sep; 38(3):565-576. PubMed ID: 35724665
[TBL] [Abstract] [Full Text] [Related]
15. Effectiveness of end-stage renal disease communication skills training for healthcare personnel: a single-center, single-blind, randomized study.
Fang JT; Chen SY; Tian YC; Lee CH; Wu IW; Kao CY; Lin CC; Tang WR
BMC Med Educ; 2022 May; 22(1):397. PubMed ID: 35606757
[TBL] [Abstract] [Full Text] [Related]
16. The tricks for fighting against cancer using CAR NK cells: A review.
Vahidian F; Khosroshahi LM; Akbarzadeh M; Jahanban-Esfahlan A; Baghbanzadeh A; Ali-Hassanzadeh M; Safarzadeh E
Mol Cell Probes; 2022 Jun; 63():101817. PubMed ID: 35436564
[TBL] [Abstract] [Full Text] [Related]
17. Development and validation of a nomogram for prediction of cervical lymph node metastasis in middle and lower thoracic esophageal squamous cell carcinoma.
Yan Z; Xu X; Lu J; You Y; Xu J; Xu T
BMC Gastroenterol; 2022 Apr; 22(1):163. PubMed ID: 35369868
[TBL] [Abstract] [Full Text] [Related]
18. Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma.
Panowski SH; Srinivasan S; Tan N; Tacheva-Grigorova SK; Smith B; Mak YSL; Ning H; Villanueva J; Wijewarnasuriya D; Lang S; Melton Z; Ghosh A; Dusseaux M; Galetto R; Heyen JR; Sai T; Van Blarcom T; Chaparro-Riggers J; Sasu BJ
Cancer Res; 2022 Jul; 82(14):2610-2624. PubMed ID: 35294525
[TBL] [Abstract] [Full Text] [Related]
19. [Prognostic value of preoperative platelet parameters in locally advanced renal cell carcinoma].
Xiao RT; Liu C; Xu CX; He W; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):647-652. PubMed ID: 34393222
[TBL] [Abstract] [Full Text] [Related]
20. [Clinical outcomes for young patients with muscular invasive bladder cancer who received robot-assisted radical cystectomy].
Wang JG; Zhu ZW; Fan YF; Zhang XP
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(12):861-865. PubMed ID: 33789368
[No Abstract] [Full Text] [Related]
[Next]
